1. Operating Room Versus Intensive Care Unit Extubation Within 6 Hours After On-Pump Cardiac Surgery: Early Results and Hospital Costs.
- Author
-
Hawkins AD, Strobel RJ, Mehaffey JH, Hawkins RB, Rotar EP, Young AM, Yarboro LT, Yount K, Ailawadi G, Joseph M, Quader M, and Teman NR
- Subjects
- Humans, Time Factors, Male, Female, Middle Aged, Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Cardiopulmonary Bypass economics, Cardiopulmonary Bypass adverse effects, Cost-Benefit Analysis, Cost Savings, Reoperation, Risk Assessment, Airway Extubation economics, Airway Extubation adverse effects, Operating Rooms economics, Hospital Costs, Length of Stay economics, Cardiac Surgical Procedures adverse effects, Cardiac Surgical Procedures economics, Cardiac Surgical Procedures mortality, Intensive Care Units economics
- Abstract
Time-directed extubation (fast-track) protocols may decrease length of stay and cost but data on operating room (OR) extubation is limited. The objective of this study was to compare the outcomes of extubation in the OR versus fast-track extubation within 6 hours of leaving the operating room. Patients undergoing nonemergent STS index cases (2011-2021) who were extubated within 6 hours were identified from a regional STS quality collaborative. Patients were stratified by extubation in the OR versus fast track. Propensity score matching (1:n) was performed to balance baseline differences. Of the 24,962 patients, 498 were extubated in the OR. After matching, 487 OR extubation cases and 899 fast track cases were well balanced. The rate of reintubation was higher for patients extubated in the OR [21/487 (4.3%) vs 16/899 (1.8%), P = 0.008] as was the incidence of reoperation for bleeding [12/487 (2.5%) vs 8/899 (0.9%), P = 0.03]. There was no significant difference in the rate of any reoperation [16/487 (3.3%) vs 15/899 (1.6%), P = 0.06] or operative mortality [4/487 (0.8%) vs 6/899 (0.6%), P = 0.7]. OR extubation was associated with shorter hospital length of stay (5.6 vs 6.2 days, P < 0.001) and lower total cost of admission ($29,602 vs $31,565 P < 0.001). OR extubation is associated with a higher postoperative risk of reintubation and reoperation due to bleeding, but lower resource utilization.Future research exploring predictors of extubation readiness may be required prior to widespread adoption of this practice., Competing Interests: Disclosures Dr. Ailawadi is a consultant and advisor for Medtronic, Inc; Edwards Lifescience; Abbott Laboratories; AtriCure and Cephea Valve Technologies. Dr. Joseph is a speaker for Angiodynamics. Dr. Yarboro has received honoraria for consulting and proctoring for Medtronic and has proctored for Abbott Laboratories., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF